Association between Genetic Variants in DNA and Histone Methylation and Telomere Length
Parks, Christine G.
DeRoo, Lisa A.
Sandler, Dale P.
Taylor, Jack A.
MetadataShow full item record
AbstractTelomere length, a biomarker of aging and age-related diseases, exhibits wide variation between individuals. Common genetic variation may explain some of the individual differences in telomere length. To date, however, only a few genetic variants have been identified in the previous genome-wide association studies. As emerging data suggest epigenetic regulation of telomere length, we investigated 72 single nucleotide polymorphisms (SNPs) in 46 genes that involve DNA and histone methylation as well as telomerase and telomere-binding proteins and DNA damage response. Genotyping and quantification of telomere length were performed in blood samples from 989 non-Hispanic white participants of the Sister Study, a prospective cohort of women aged 35–74 years. The association of each SNP with logarithmically-transformed relative telomere length was estimated using multivariate linear regression. Six SNPs were associated with relative telomere length in blood cells with p-values<0.05 (uncorrected for multiple comparisons). The minor alleles of BHMT rs3733890 G>A (p = 0.041), MTRR rs2966952 C>T (p = 0.002) and EHMT2 rs558702 G>A (p = 0.008) were associated with shorter telomeres, while minor alleles of ATM rs1801516 G>A (p = 0.031), MTR rs1805087 A>G (p = 0.038) and PRMT8 rs12299470 G>A (p = 0.019) were associated with longer telomeres. Five of these SNPs are located in genes coding for proteins involved in DNA and histone methylation. Our results are consistent with recent findings that chromatin structure is epigenetically regulated and may influence the genomic integrity of telomeric region and telomere length maintenance. Larger studies with greater coverage of the genes implicated in DNA methylation and histone modifications are warranted to replicate these findings.
CitationPLoS One. 2012 Jul 11; 7(7):e40504
- Genetic variation and human longevity.
- Authors: Soerensen M
- Issue date: 2012 May
- Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres.
- Authors: Benetti R, García-Cao M, Blasco MA
- Issue date: 2007 Feb
- The association of telomere length and genetic variation in telomere biology genes.
- Authors: Mirabello L, Yu K, Kraft P, De Vivo I, Hunter DJ, Prescott J, Wong JY, Chatterjee N, Hayes RB, Savage SA
- Issue date: 2010 Sep
- Telomeres, histone code, and DNA damage response.
- Authors: Misri S, Pandita S, Kumar R, Pandita TK
- Issue date: 2008
- Histone Modifications and the Maintenance of Telomere Integrity.
- Authors: Jezek M, Green EM
- Issue date: 2019 Feb 25
Showing items related by title, author, creator and subject.
Molecular Chaperone Function of Site-Directed Mutants of αA- and αB-CrystallinsShroff, Nilufer P.; Department of Biochemistry and Molecular Biology (1999-06)(Statement of the Problem) Cataract formation causes blindness in more than 17 million people worldwide (1). The only treatment present to date is lens surgery. The magnitude of this problem and the limitations o f cataract surgery have stimulated research in animals as well as in vitro studies and epidemiological studies. Research in this field is directed towards preventing or at least delaying cataract development. A thorough understanding of the process of cataractogenesis and the mechanisms involved is essential for the advancement in this area. a-Crystallin, a major lens protein belonging to the heat-shock protein family, play a role in maintaining lens transparency because of its ability to function as a chaperone, (i.e. having the ability to suppress aggregation o f other lens proteins which cause lens opacity). Oxidative modifications and hydrophobic interactions of certain amino acid residues could affect the chaperone function of a-crystallin. Congenital cataracts are a major cause of blindness in infants and some are due to mutations occurring in crystallins including a-crystallin. The current study investigated the impact of three types o f modifications on the chaperone-like function of a-crystallin. The modifications were 1) oxidation, 2) the presence of specific hydrophobic or hydrophilic amino acid residues and 3) a mutation which has been identified as the cause of an autosomal congenital cataract in humans.
Incidence and survival trends of colorectal cancer from 2002 to 2011Ansa, Benjamin E.; Alema-Mensah, Ernest; Claridy, Mechelle D.; Sheats, Joyce Q.; Smith, Selina A.; School of Medicine; Georgia Regents University; Morehouse College (2015-03)
Triple-negative breast cancer in Georgia: Burden, disparities, and connections to Georgia’s Breast Cancer Genomics ProjectBerzen, Alissa; Bayakly, Rana (Georgia Public Health Association, 2017)Background: Triple negative breast cancer (TNBC) is typically aggressive and unresponsive to traditional cancer treatment, and disproportionately affects young and Black women. Approximately 60%-80% of breast cancers in women with the breast cancer gene (BRCA) mutation are TNBC, and children of a parent with a BRCA mutation have a 50% chance of inheriting it. Current guidelines recommend women diagnosed with TNBC receive genetic testing and counseling. Georgia’s Breast and Cervical Cancer Program (BCCP) routinely screens clients for increased risk of genetic mutation via an online screening tool. Methods: Using data from the Georgia Comprehensive Cancer Registry (GCCR) for 2010-2013, we calculated TNBC percentages/rates, diagnosis stage, and case fatality rate based on vital status. By using TNBC data as a proxy for BRCA gene mutation prevalence, we assessed the burden of TNBC and racial/age disparities to inform Georgia’s genomics efforts. Results: The percentage of invasive breast cancers, versus in-situ, was the same for Georgia Black and White women; however, Black women had almost double the percentage of TNBC as compared to White women. Black women under 40 had a 20% higher breast cancer incidence rate than similarly aged White women, but had almost double the TNBC rate. Georgia TNBC cases were about twice as likely as non-TNBC cases to be deceased, and Black TNBC cases had higher fatality rates than White cases (almost twice as high in women under 40). Conclusions: Georgia’s genomics program began screening in 2012, and participating counties offer screening to all women’s health clients. Awareness of hormone receptor status (and furthermore, possible presence of genetic mutation) for women diagnosed with breast cancer can guide the proper course of treatment. Additionally, family members of women diagnosed with TNBC in Georgia may take advantage of the screening for risk of genetic mutation through the genomics program prior to a cancer diagnosis, and receive counseling where appropriate.